Scilex Holding (SCLXW) Share-based Compensation (2022 - 2026)

Scilex Holding (SCLXW) recorded quarterly Share-based Compensation of $3.6 million in Q1 2026, up 148.72% quarter-over-quarter from -$7.4 million in Q4 2025, and up 9.51% on a YoY basis from $3.3 million in Q1 2025.

Scilex Holding (SCLXW) Share-based Compensation (2022 - 2026) Analysis & Trends

Scilex Holding's Share-based Compensation history runs 5 years deep, the most recent figure standing at $3.6 million for Q1 2026.

  • In Q1 2026, Share-based Compensation rose 9.51% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $2.7 million (down 82.42% YoY), while the FY2025 annual figure was $2.4 million, down 84.7% from the prior year.
  • Share-based Compensation was $3.6 million for Q1 2026 at Scilex Holding, up from -$7.4 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $4.8 million in Q4 2024 to a low of -$7.4 million in Q4 2025.
  • Historically, Share-based Compensation has averaged $2.4 million across 5 years, with a median of $3.5 million in 2023.
  • The sharpest annual moves came in 2023 and 2025: Share-based Compensation surged 201.92% in 2023, then tumbled 255.03% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $1.3 million in 2022, then soared by 201.92% to $3.8 million in 2023, then grew by 27.02% to $4.8 million in 2024, then sank by 255.03% to -$7.4 million in 2025, then surged by 148.72% to $3.6 million in 2026.
  • The last three Share-based Compensation figures came in at $3.6 million (Q1 2026), -$7.4 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 161.00 Mn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 300.00 Mn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 444.00 Mn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 185.00 Mn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 75.00 Mn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 218.00 Mn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 272.00 Mn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 146.00 Mn
10 Scilex Holding - - 4.15 Mn 3.63 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.63 Mn
Mar 31, 2026 3.63 Mn
Dec 31, 2025 -7.45 Mn
Dec 31, 2025 -7.45 Mn
Sep 30, 2025 3.26 Mn
Sep 30, 2025 3.26 Mn
Jun 30, 2025 3.28 Mn
Jun 30, 2025 3.28 Mn
Mar 31, 2025 3.31 Mn
Mar 31, 2025 3.31 Mn
Dec 31, 2024 4.81 Mn
Dec 31, 2024 4.81 Mn
Sep 30, 2024 3.71 Mn
Sep 30, 2024 3.71 Mn
Jun 30, 2024 3.61 Mn
Jun 30, 2024 3.61 Mn
Mar 31, 2024 3.56 Mn
Mar 31, 2024 3.56 Mn
Dec 31, 2023 3.78 Mn
Dec 31, 2023 3.78 Mn